Report ID: SQMIG35D2046
Report ID:
SQMIG35D2046 |
Region:
Global |
Published Date: August, 2024
Pages:
157
|
Tables:
98 |
Figures:
76
Next Generation Sequencing Market size was valued at USD 9.27 Billion in 2023 and is poised to grow from USD 10.98 Billion in 2024 to USD 42.71 Billion by 2032, growing at a CAGR of 18.5% during the forecast period (2025-2032).
Next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS is less dependent on fragment-cloning strategies that are used in Sanger genome sequencing. The advantages of NGS over Sanger’s sequencing method include low cost, high accuracy and speed, precise results even if small amounts of samples are used. Thus, NGS is widely used in biomarker discovery, cancer studies, personalized medicine, agriculture and animal studies, etc.
Genome sequencing has also been applied to understanding how Covid-19 spreads and can inform how interventions affect disease progression and subsequent treatments. The Covid-19 Genomics U.K. Consortium (COG-U.K.) was set up in March 2020, to utilize Whole-Genome Sequencing to investigate the coronavirus genome. Partners in the cooperation are the Welcome Sanger Institute, the NHS, Public Health Agencies, and other academic institutions. These organizations have collaborated on mapping the virus’s evolution and spread.
US Next Generation Sequencing Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2046